Clinical Trials Browser

Phase 2 × Interventional × Gels × Clear all

NCT04570956 2026-01-23

Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk

Phase 2 Terminated

65 enrolled

Breast

Breast Carcinoma In Situ, Breast Neoplasms

NCT04301765 2025-03-11

TEMEC

Phase 2 Recruiting

230 enrolled

Eunuchism, Fatigue, Hypogonadism, Neoplasms

NCT06577311 2024-08-29

Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis)

Phase 2 Recruiting

20 enrolled

DermatologicGynecologic

Squamous Intraepithelial Lesions, Carcinoma, Squamous Cell, Skin Neoplasms

NCT05800834 2023-09-28

MorphineGEL

Phase 2 Unknown

106 enrolled

BreastHead & Neck

Cancer Pain, Breast Neoplasms, Head and Neck Neoplasms, Wounds and Injuries

NCT02462187 2023-04-06

Topical NVN1000 for the Treatment of External Genital and Perianal Warts

Phase 2 Completed

108 enrolled 19 charts

Condylomata Acuminata

NCT01874860 2022-12-01

Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients

Phase 2 Completed

24 enrolled

GastrointestinalHead & Neck

Head and Neck Neoplasms, Colorectal Neoplasms

NCT03380026 2021-11-24

MIDAS

Phase 2 Completed

28 enrolled 8 charts

DermatologicLymphoid

Dermatitis, Contact, Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

NCT02724254 2018-07-20

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients

Phase 2 Completed

218 enrolled

Condylomata Acuminata, Sexually Transmitted Diseases, Virus Diseases, Papillomavirus Infections

NCT02596074 2017-08-03

Pharmacodynamics, Safety/Tolerability and Efficacy of Topical Omiganan in Patients With uVIN

Phase 2 Completed

12 enrolled

Usual Type Vulval Intraepithelial Neoplasia (uVIN)

NCT02849262 2017-03-31

Pharmacodynamics, Safety and Efficacy of Topical Omiganan in Patients With External Genital Warts

Phase 2 Completed

24 enrolled

Condylomata Acuminata

NCT02145884 2017-02-13

Topical Timolol Gel for the Treatment of Infantile Hemangiomas

Phase 2 Completed

26 enrolled

Hemangioma, Hemangioma, Cavernous

NCT00852137 2015-03-06

A Study to Evaluate the Pharmacokinetics of PEP005 (Ingenol Mebutate) Gel, 0.05%, When Applied in a Maximal Use Setting to the Dorsal Aspect of the Forearm in Patients With Actinic Keratosis

Phase 2 Completed

16 enrolled 9 charts

Dermatologic

Keratosis, Actinic

NCT00322296 2013-04-16

Phase II Trial to Evaluate the Efficacy of Topical Bexarotene Gel in Patients With Parapsoriasis

Phase 2 Terminated

8 enrolled

DermatologicLymphoid

Mycosis Fungoides, Parapsoriasis, Lymphoma, T-Cell, Cutaneous

NCT00343187 2011-05-30

A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash

Phase 2 Terminated

2 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Exanthema

NCT01214564 2011-01-25

Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic Keratosis

Phase 2 Completed

24 enrolled

Dermatologic

Keratosis, Seborrheic, Keratosis, Actinic